Dr. Reddy’s Laboratories Ltd. on Friday announced its launch of Doxycycline Capsules, 40 mg in the U.S. market. According to the company’s press statement, it is a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30. ORACEA is a trademark of Galderma Holdings, S.A.
It is a broad-spectrum antibiotic and it is used in the treatment of infections caused by bacteria and certain parasites. It is used to treat bacterial pneumonia, acne, chlamydia infections, Lyme disease, cholera, typhus, and syphilis. It is also used to prevent malaria.
Read Next
